# ABCA4

## Overview
The ABCA4 gene encodes the ATP-binding cassette subfamily A member 4 (ABCA4) protein, which is a critical component of the ATP-binding cassette (ABC) transporter family. This transmembrane protein is predominantly expressed in the photoreceptor cells of the retina, where it plays a vital role in the visual cycle by transporting retinoid compounds across cell membranes. The ABCA4 protein facilitates the movement of N-retinylidene-phosphatidylethanolamine (N-retinylidene-PE), a key intermediate in the visual process, thereby preventing the accumulation of toxic byproducts that can lead to retinal degeneration (Tsybovsky2010The; Molday2009The). Mutations in the ABCA4 gene are linked to several retinal diseases, most notably Stargardt disease, which is characterized by progressive vision loss (Rivera2000A). The protein's function is regulated by ATP binding and hydrolysis, which drive the conformational changes necessary for its transport activity (Molday2009The). Understanding the structure and function of ABCA4 is crucial for developing therapeutic strategies for associated retinal disorders.

## Structure
The ABCA4 protein is a large single polypeptide consisting of 2273 amino acids, organized into two homologous halves, each containing specific structural domains. The primary structure includes highly conserved motifs such as the ABC transporter signature motif 'LSGGQ' in the nucleotide-binding domains (NBDs), although it is reduced to 'SGG' in NBD2 (Tsybovsky2010The). The secondary structure features transmembrane domains (TMDs) with six alpha-helices in each half, forming a total of 12 transmembrane helices (Tsybovsky2010The). 

The tertiary structure of ABCA4 includes two TMDs responsible for substrate binding and forming the translocation path, and two NBDs that provide energy for transport by hydrolyzing ATP (Tsybovsky2010The). The protein also contains large glycosylated exocytoplasmic domains (ECDs) located inside the disk, which are linked by disulfide bonds and contain multiple N-linked glycosylation sites (Tsybovsky2010The; Liu2021Molecular). 

In terms of quaternary structure, ABCA4 functions as a dimer, with the N-terminal and C-terminal moieties potentially interacting (Tsybovsky2010The). The protein's structure is similar to the torch-shaped hABCA1, with a type II ABC exporter fold in its TMDs (Xie2021Structural). The presence of splice variant isoforms is suggested, affecting its function and localization (Cevik2023Structural).

## Function
The ABCA4 gene encodes a protein that is a member of the ATP-binding cassette (ABC) transporter family, specifically expressed in the photoreceptor cells of the retina. This protein plays a crucial role in the visual cycle by facilitating the transport of retinoid compounds across photoreceptor cell membranes. In healthy human cells, ABCA4 is involved in the transport of N-retinylidene-phosphatidylethanolamine (N-retinylidene-PE), a Schiff base product formed from all-trans retinal and phosphatidylethanolamine (PE), from the lumen to the cytoplasmic side of the disc membrane in photoreceptors (Tsybovsky2010The; Molday2009The).

This transport process is essential for the clearance of all-trans retinal, preventing the accumulation of toxic byproducts such as A2E, which can lead to lipofuscin deposits in retinal pigment epithelial cells. These deposits are associated with retinal degenerative diseases like Stargardt disease (Molday2009The). The activity of ABCA4 is regulated by ATP binding and hydrolysis, which induces conformational changes necessary for the transport cycle (Tsybovsky2010The; Molday2009The). The proper functioning of ABCA4 is critical for maintaining photoreceptor health and preventing vision loss (Molday2009The).

## Clinical Significance
Mutations in the ABCA4 gene are primarily associated with Stargardt disease (STGD), an autosomal recessive macular dystrophy that leads to progressive central vision impairment, typically beginning in childhood or young adulthood (Rivera2000A). The gene is also implicated in other retinal diseases, including cone-rod dystrophy (CRD) and retinitis pigmentosa (RP) (Zernant2011Analysis; Klevering2004The). ABCA4-related retinal diseases encompass a range of disorders that were previously considered distinct but are now understood to have a common genetic basis (Klevering2004The).

The severity of these conditions is often correlated with the type of ABCA4 mutations. For instance, nullizygosity for ABCA4 is associated with early onset cone-rod dysfunction and rapid progression of central atrophy (Fakin2016Phenotype). The accumulation of toxic substances like lipofuscin in the retinal pigment epithelium, due to dysfunctional ABCA4 protein, is a hallmark of these diseases (Cremers2020Clinical).

ABCA4 mutations have also been investigated for their potential role in age-related macular degeneration (AMD). While some studies suggest an increased frequency of heterozygous ABCA4 alterations in AMD patients, the association remains debated (Rivera2000A; Zernant2017Frequent).

## Interactions
The ABCA4 protein, a member of the ATP-binding cassette (ABC) transporter family, is primarily involved in the transport of retinoids across photoreceptor cell membranes. While specific protein interactions of ABCA4 are not extensively detailed, its structural features suggest potential interactions with other proteins. The exocytoplasmic domains of ABCA4, which are glycosylated and linked by disulfide bonds, may interact with proteins similar to how related transporters like ABCA1 interact with apolipoprotein A-I (Tsybovsky2010The). 

The extracellular domains (ECDs) of ABCA4 form a network of α-helices and β-sheets, which are crucial for the protein's function and may facilitate interactions with other proteins, although specific interactions are not explicitly mentioned (Scortecci2021CryoEM). The potential for weak interactions with other disc rim proteins is noted, highlighting the importance of structural domains for ABCA4's function (Scortecci2021CryoEM). 

Mutations in ABCA4 are linked to Stargardt disease, and these mutations can affect the protein's interaction with its substrate, N-Ret-PE, and potentially with other proteins involved in the visual cycle (Scortecci2021CryoEM). However, detailed interactions with nucleic acids or specific protein partners are not provided in the available context.


## References


[1. (Tsybovsky2010The) Yaroslav Tsybovsky, Robert S. Molday, and Krzysztof Palczewski. The ATP-Binding Cassette Transporter ABCA4: Structural and Functional Properties and Role in Retinal Disease, pages 105–125. Springer New York, 2010. URL: http://dx.doi.org/10.1007/978-1-4419-5635-4_8, doi:10.1007/978-1-4419-5635-4_8. This article has 144 citations.](https://doi.org/10.1007/978-1-4419-5635-4_8)

[2. (Rivera2000A) Andrea Rivera, Karen White, Heidi Stöhr, Klaus Steiner, Nadine Hemmrich, Timo Grimm, Bernhard Jurklies, Birgit Lorenz, Hendrik P.N. Scholl, Eckhart Apfelstedt-Sylla, and Bernhard H.F. Weber. A comprehensive survey of sequence variation in the abca4 (abcr) gene in stargardt disease and age-related macular degeneration. The American Journal of Human Genetics, 67(4):800–813, October 2000. URL: http://dx.doi.org/10.1086/303090, doi:10.1086/303090. This article has 222 citations.](https://doi.org/10.1086/303090)

[3. (Liu2021Molecular) Fangyu Liu, James Lee, and Jue Chen. Molecular structures of the eukaryotic retinal importer abca4. eLife, February 2021. URL: http://dx.doi.org/10.7554/elife.63524, doi:10.7554/elife.63524. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.63524)

4. (Xie2021Structural) Structural basis of substrate recognition and translocation by human ABCA4. This article has 0 citations.

[5. (Zernant2017Frequent) Jana Zernant, Winston Lee, Frederick T Collison, Gerald A Fishman, Yuri V Sergeev, Kaspar Schuerch, Janet R Sparrow, Stephen H Tsang, and Rando Allikmets. Frequent hypomorphic alleles account for a significant fraction of abca4 disease and distinguish it from age-related macular degeneration. Journal of Medical Genetics, 54(6):404–412, April 2017. URL: http://dx.doi.org/10.1136/jmedgenet-2017-104540, doi:10.1136/jmedgenet-2017-104540. This article has 140 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2017-104540)

[6. (Molday2009The) Robert S. Molday, Ming Zhong, and Faraz Quazi. The role of the photoreceptor abc transporter abca4 in lipid transport and stargardt macular degeneration. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1791(7):573–583, July 2009. URL: http://dx.doi.org/10.1016/j.bbalip.2009.02.004, doi:10.1016/j.bbalip.2009.02.004. This article has 122 citations.](https://doi.org/10.1016/j.bbalip.2009.02.004)

[7. (Fakin2016Phenotype) Ana Fakin, Anthony G. Robson, Kaoru Fujinami, Anthony T. Moore, Michel Michaelides, John (Pei-Wen) Chiang, Graham E. Holder, and Andrew R. Webster. Phenotype and progression of retinal degeneration associated with nullizigosity of abca4. Investigative Opthalmology &amp; Visual Science, 57(11):4668, September 2016. URL: http://dx.doi.org/10.1167/iovs.16-19829, doi:10.1167/iovs.16-19829. This article has 35 citations.](https://doi.org/10.1167/iovs.16-19829)

[8. (Cremers2020Clinical) Frans P.M. Cremers, Winston Lee, Rob W.J. Collin, and Rando Allikmets. Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by abca4 mutations. Progress in Retinal and Eye Research, 79:100861, November 2020. URL: http://dx.doi.org/10.1016/j.preteyeres.2020.100861, doi:10.1016/j.preteyeres.2020.100861. This article has 197 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.preteyeres.2020.100861)

[9. (Cevik2023Structural) Senem Cevik, Subhasis B. Biswas, and Esther E. Biswas-Fiss. Structural and pathogenic impacts of abca4 variants in retinal degenerations—an in-silico study. International Journal of Molecular Sciences, 24(8):7280, April 2023. URL: http://dx.doi.org/10.3390/ijms24087280, doi:10.3390/ijms24087280. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24087280)

[10. (Scortecci2021CryoEM) Jessica Fernandes Scortecci, Laurie L. Molday, Susan B. Curtis, Fabian A. Garces, Pankaj Panwar, Filip Van Petegem, and Robert S. Molday. Cryo-em structures of the abca4 importer reveal mechanisms underlying substrate binding and stargardt disease. Nature Communications, October 2021. URL: http://dx.doi.org/10.1038/s41467-021-26161-7, doi:10.1038/s41467-021-26161-7. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-26161-7)

[11. (Zernant2011Analysis) Jana Zernant, Carl Schubert, Kate M. Im, Tomas Burke, Carolyn M. Brown, Gerald A. Fishman, Stephen H. Tsang, Peter Gouras, Michael Dean, and Rando Allikmets. Analysis of theabca4gene by next-generation sequencing. Investigative Opthalmology &amp; Visual Science, 52(11):8479, October 2011. URL: http://dx.doi.org/10.1167/iovs.11-8182, doi:10.1167/iovs.11-8182. This article has 108 citations.](https://doi.org/10.1167/iovs.11-8182)

[12. (Klevering2004The) B. Jeroen Klevering, August F. Deutman, Alessandra Maugeri, Frans P. M. Cremers, and Carel B. Hoyng. The spectrum of retinal phenotypes caused by mutations in the abca4 gene. Graefe’s Archive for Clinical and Experimental Ophthalmology, 243(2):90–100, December 2004. URL: http://dx.doi.org/10.1007/s00417-004-1079-4, doi:10.1007/s00417-004-1079-4. This article has 74 citations.](https://doi.org/10.1007/s00417-004-1079-4)